Medicare Benefits Schedule - Item 73395

Re‑analysis of whole exome or genome data that is obtained in performing a service to which item 73392 applies, for characterisation of previously unreported germline gene variants related to the clinical phenotype, if:

(a) the re-analysis is requested by a consultant physician practising as a clinical geneticist or a cardiologist; and

(b) the patient is strongly suspected of having a heritable cardiomyopathy; and

(c) the re-analysis is performed at least 18 months after a service to which item 73392 or this item applies is performed for the patient

Applicable twice per lifetime

Fee: $500.00 Benefit: 75% = $375.00 85% = $425.00

(See para PN.0.27 of explanatory notes to this Category)

• Previous - Item 73394
• Next - Item 73396

Items 73295, 73296, 73304, 73333, 73392, 73395, 73416 and 73419.

Patients who are found to have any form of affected allele should be referred for post-test genetic counselling as there may be implications for other family members. Appropriate genetic counselling should be provided to the patient either by the specialist treating practitioner, a genetic counselling service or a clinical geneticist on referral.

Items 73416 and 73392

The rapidly expanding field of genomic medicine has resulted in recognition of an increasing number of genetic causes of
cardiac diseases. Use of genomic testing methods that permit reanalysis of existing data for variants in newly described
clinically relevant genes are recommended/encouraged.

Related Items: 73295 73296 73304 73333 73392 73395 73416 73419